Valeo Pharma
Logotype for Valeo Pharma Inc

Valeo Pharma (VPH) investor relations material

Valeo Pharma has been otc

Valeo Pharma Q3 2024 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Valeo Pharma Inc
Q3 2024 earnings summary13 Sep, 2024

Executive summary

  • Q3 2024 revenues were CAD 12.6 million, down 11% year-over-year, mainly due to the loss or termination of Xiidra commercialization, but core business/brands grew 9% year-over-year.

  • Adjusted EBITDA loss improved to CAD 1.5 million in Q3 2024 from CAD 2.5 million in Q3 2023, a 40% reduction.

  • Net loss increased to CAD 8.2 million in Q3 2024 from CAD 5.8 million in Q3 2023, driven by Xiidra loss and restructuring costs.

  • Cost-saving initiatives and restructuring since late 2023 have begun to materialize, with further improvements expected.

  • Enerzair and Atectura prescriptions rose 74% year-over-year, with prescribing physicians up 71%.

Financial highlights

  • Q3 2024 gross profit was CAD 3.9 million, down 12% from CAD 4.4 million in Q3 2023, mainly due to Xiidra transfer.

  • Adjusted EBITDA loss improved to CAD 1.5 million in Q3 2024 from CAD 2.5 million in Q3 2023.

  • Net loss increased to CAD 8.2 million in Q3 2024 from CAD 5.8 million in Q3 2023, impacted by lower gross profit and CAD 1.6 million in restructuring costs.

  • Year-to-date revenues were CAD 40.3 million, nearly flat versus CAD 40.8 million in the prior year.

  • Year-to-date adjusted EBITDA loss improved 5% to CAD 6.1 million.

Outlook and guidance

  • Continued revenue growth expected from core therapeutic assets/brands and further OpEx reductions.

  • Targeting EBITDA positive in Q1 2025.

  • Cost reduction measures from respiratory business restructuring expected to decrease annual operating expenses by over CAD 5 million.

  • Anticipates further growth in REDESCA as Ontario market impact materializes.

  • Ongoing business development to expand the ophthalmology portfolio.

Impact of Q4 one-time costs on EBITDA target
Redesca: Ontario delisting impact timing and scale
Convertible debt refinancing plan details
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Valeo Pharma
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Valeo Pharma Inc. is a specialty pharmaceutical company engaged in the acquisition, in-licensing brands and sale of pharmaceutical products with primary focus on respiratory, speciality and hospital generic products in Canada. The Company's core competencies include clinical research, regulatory affairs and drug safety. The Company focuses on marketing approved products through its prescription division as well as niche markets such as respiratory through specialty divisions.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage